Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life

Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life

Nonalcoholic steatohepatitis (NASH) is a prevalent chronic disease that is associated with a spectrum of liver fibrosis and can lead to cirrhosis. Patients with NASH report lower health-related quality of life (HRQoL) than the general population. It remains uncertain how changes in histologic severi...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Heath, L, Aveyard, P, Tomlinson, J, Cobbold, JF, Koutoukidis, DA
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Wiley 2022

Eitemau Tebyg

Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life
gan: Laura Heath, et al.
Cyhoeddwyd: (2022-10-01)

Association of weight changes with changes in histological features and blood markers in non-alcoholic steatohepatitis
gan: Koutoukidis, D, et al.
Cyhoeddwyd: (2021)

A low-energy total diet replacement programme demonstrates a favourable safety profile and improves liver disease severity in non-alcoholic steatohepatitis
gan: Koutoukidis, D, et al.
Cyhoeddwyd: (2023)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
gan: Singh Deepak, et al.
Cyhoeddwyd: (2010-07-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
gan: "Ebrahimi Daryani N, et al.
Cyhoeddwyd: (2003-03-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
gan: "Ebrahimi Daryani N, et al.
Cyhoeddwyd: (2003-05-01)

Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis
gan: Dimitrios A. Koutoukidis, et al.
Cyhoeddwyd: (2024-12-01)

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
gan: Hyeong Geug Kim, et al.
Cyhoeddwyd: (2021-07-01)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
gan: Dowman, J, et al.
Cyhoeddwyd: (2011)

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis
gan: Koutoukidis, DA, et al.
Cyhoeddwyd: (2021)

Changes in rat liver fatty acid profile in experimental non-alcoholic steatohepatitis
gan: E. B. Shustov, et al.
Cyhoeddwyd: (2021-12-01)

Non-alcoholic Steatohepatitis: An Overview
gan: Allison Shifflet, et al.
Cyhoeddwyd: (2009-01-01)

Endocannabinoids and non-alcoholic steatohepatitis
gan: Helmy Ahmed
Cyhoeddwyd: (2006-01-01)

Statins in Non-alcoholic Steatohepatitis
gan: Jose D. Torres-Peña, et al.
Cyhoeddwyd: (2021-11-01)

Fructose and Non-Alcoholic Steatohepatitis
gan: Elke Roeb, et al.
Cyhoeddwyd: (2021-02-01)

Non-alcoholic steatohepatitis in pregnancy: a case report
gan: Jonathan Cordivani, et al.
Cyhoeddwyd: (2023-09-01)

Obesity, self-reported symptom severity, and quality of life in people with atrial fibrillation: A community-based cross-sectional survey
gan: Koutoukidis, D, et al.
Cyhoeddwyd: (2020)

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
gan: Dimitrios A Koutoukidis, et al.
Cyhoeddwyd: (2021-01-01)

The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes
gan: Zobair Younossi, et al.
Cyhoeddwyd: (2022-09-01)

Role of alcohol metabolism in non-alcoholic steatohepatitis.
gan: Susan S Baker, et al.
Cyhoeddwyd: (2010-03-01)

Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis
gan: Éder Marcolin, et al.
Cyhoeddwyd: (2011-03-01)

Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse model
gan: Mitsugu Watanabe, et al.
Cyhoeddwyd: (2016-01-01)

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.
gan: Newsome, P, et al.
Cyhoeddwyd: (2012)

Liraglutide for patients with non-alcoholic steatohepatitis.
gan: Dale, A, et al.
Cyhoeddwyd: (2016)

Therapeutic approaches for non-alcoholic steatohepatitis
gan: Luc F. Van Gaal, et al.
Cyhoeddwyd: (2021-09-01)

Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
gan: Rudolf E. Stauber, et al.
Cyhoeddwyd: (2024-05-01)

Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing
gan: Diogo Pellegrina, et al.
Cyhoeddwyd: (2023-05-01)

Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis
gan: Feng Liu, et al.
Cyhoeddwyd: (2022-06-01)

Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
gan: Shahinul Alam, et al.
Cyhoeddwyd: (2016-01-01)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
gan: Armstrong, M, et al.
Cyhoeddwyd: (2015)

Association of weight loss interventions with changes in biomarkers of non-alcoholic fatty liver disease: A systematic review and meta-analysis
gan: Koutoukidis, DA, et al.
Cyhoeddwyd: (2019)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
gan: Ye. A. Fedos’ina, et al.
Cyhoeddwyd: (2010-06-01)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
gan: Oksana Khukhlina, et al.
Cyhoeddwyd: (2021-05-01)

Non-Alcoholic Steatohepatitis: Clinical and Translational Research
gan: Manuela G Neuman, et al.
Cyhoeddwyd: (2016-01-01)

Progress on cholesterol metabolism and non-alcoholic steatohepatitis
gan: LI Xiao-xiao, SHU Xiang-bing, ZHANG Li
Cyhoeddwyd: (2022-07-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
gan: Gregory Habig, et al.
Cyhoeddwyd: (2021-04-01)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
gan: Therese Adrian, et al.
Cyhoeddwyd: (2022-01-01)

Conophylline inhibits non-alcoholic steatohepatitis in mice.
gan: Yukiomi Nakade, et al.
Cyhoeddwyd: (2017-01-01)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
gan: Rafael S. Rios, et al.
Cyhoeddwyd: (2021-12-01)

Silymarin and management of liver function in non-alcoholic steatohepatitis: a case report
gan: Ahmed Hashem
Cyhoeddwyd: (2023-06-01)